These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of cholinergic and anticholinergic agents on tardive dyskinesia. Klawans HL; Rubovits R J Neurol Neurosurg Psychiatry; 1974 Aug; 37(8):941-7. PubMed ID: 4418481 [TBL] [Abstract][Full Text] [Related]
3. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia. Pind K; Faurbye A Acta Psychiatr Scand; 1970; 46(4):323-6. PubMed ID: 4323062 [No Abstract] [Full Text] [Related]
4. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Davis KL; Berger PA Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524 [TBL] [Abstract][Full Text] [Related]
5. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome. Jus K; Jus A; Gautier J; Villeneuve A; Pires P; Pineau R; Villeneuv R Int J Clin Pharmacol; 1974 Mar; 9(2):138-45. PubMed ID: 4827556 [No Abstract] [Full Text] [Related]
6. Lithium carbonate in the treatment of tardive dyskinesia. Reda FA; Escobar JI; Scanlan JM Am J Psychiatry; 1975 May; 132(5):560-2. PubMed ID: 804260 [TBL] [Abstract][Full Text] [Related]
7. Clinical observations of the treatment of tardive dyskinesia with haloperidol. Frangos E; Christodoulides H Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948 [TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs. Crane GE Agressologie; 1968; 9(2):209-18. PubMed ID: 5675488 [No Abstract] [Full Text] [Related]
9. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome]. Kamianov IM; Kupisk AG; Katsen IZ Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581 [No Abstract] [Full Text] [Related]
10. Cholinergic influences in tardive dyskinesia. Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054 [TBL] [Abstract][Full Text] [Related]
11. Pseudoparkinsonism and tardive dyskinesia. Crane GE Arch Neurol; 1972 Nov; 27(5):426-30. PubMed ID: 5078897 [No Abstract] [Full Text] [Related]
12. Letter: Deanol in tardive dyskinesia. Tarsy D N Engl J Med; 1974 Dec; 291(26):1416. PubMed ID: 4427649 [No Abstract] [Full Text] [Related]
16. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs. Turek I; Kurland AA; Hanlon TE; Bohm M Br J Psychiatry; 1972 Dec; 121(565):605-12. PubMed ID: 4648433 [No Abstract] [Full Text] [Related]
17. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Gerlach J; Reisby N; Randrup A Psychopharmacologia; 1974 Jan; 34(1):21-35. PubMed ID: 4593518 [No Abstract] [Full Text] [Related]
18. Epidemiology of tardive dyskinesia. Part II. Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344 [TBL] [Abstract][Full Text] [Related]
19. Deanol in tardive dyskinesia. De Silva L; Huang CY Br Med J; 1975 Aug; 3(5981):466. PubMed ID: 1156821 [No Abstract] [Full Text] [Related]
20. [The semiology of motor function disorders during treatment with neuroleptic drugs]. Fleĭs EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943 [No Abstract] [Full Text] [Related] [Next] [New Search]